Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income) Per Share

v3.21.1
Net (Loss) Income) Per Share
6 Months Ended
Mar. 31, 2021
Net (Loss) Income Per Share [Abstract]  
Net Income (Loss) Per Share

Note 15 – Net (Loss) Income Per Share



Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding for the period. Diluted net (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and common stock purchase warrants as determined under the treasury stock method. 



The following table provides a reconciliation of the net (loss) income per basic and diluted common share outstanding:





 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2021

 

2020

 

2021

 

2020



 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

$

(2,845,981)

 

$

(810,509)

 

$

14,381,720 

 

$

(4,115,610)



 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

75,175,077 

 

 

65,367,493 

 

 

72,717,621 

 

 

65,202,103 

Net effect of dilutive instruments:

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 —

 

 

 —

 

 

7,147,372 

 

 

 —

Stock appreciation rights

 

 —

 

 

 —

 

 

44,256 

 

 

 —

Common stock purchase warrants

 

 —

 

 

 —

 

 

744,821 

 

 

 —

Total net effect of dilutive instruments

 

 —

 

 

 —

 

 

7,936,449 

 

 

 —

Diluted weighted average common shares outstanding

 

75,175,077 

 

 

65,367,493 

 

 

80,654,070 

 

 

65,202,103 

Net (loss) income per basic common share outstanding

$

(0.04)

 

$

(0.01)

 

$

0.20 

 

$

(0.06)

Net (loss) income per diluted common share outstanding

$

(0.04)

 

$

(0.01)

 

$

0.18 

 

$

(0.06)



For the six months ended March 31, 2021,  approximately 211,000 potentially dilutive instruments were excluded from the computation of net income per diluted weighted average common share outstanding because their effect would have been antidilutive. Due to our net loss for the three months ended March 31, 2021 and three and six months ended March 31, 2020, all potentially dilutive instruments were excluded because their inclusion would have been anti-dilutive. See Notes 9 and 10 for a discussion of our potentially dilutive instruments.